title: IRF5 risk polymorphisms contribute to interindividual variance in pattern recognition receptor-mediated cytokine secretion in human monocyte-derived cells.
abstract: Monocyte-derived cells display highly variable cytokine secretion upon pattern recognition receptor (PRR) stimulation across individuals; such variability likely affects interindividual inflammatory/autoimmune disease susceptibility. To define mechanisms for this heterogeneity, we examined PRR-induced monocyte-derived cell cytokine secretion from a large cohort of healthy individuals. Although cytokine secretion ranged widely among individuals, the magnitude of cytokine induction after individual nucleotide-binding oligomerization domain 2 (Nod2) and TLR2 stimulation (a cohort of 86 individuals) or stimulation of multiple TLRs (a cohort of 77 individuals), either alone or in combination with Nod2, was consistent intraindividually across these stimuli. Nod2 and TLRs signal through IFN regulatory factor 5 (IRF5), and common IRF5 polymorphisms confer risk for autoimmunity. We find that cells from rs2004640 IRF5 risk-associated allele carriers secrete increased cytokines upon individual or synergistic PRR stimulation in a gene dose- and ligand dose-dependent manner in both monocyte-derived dendritic cells and monocyte-derived macrophages. IRF5 expression knockdown in IRF5 risk allele carrier cells significantly decreases PRR-induced cytokines. Moreover, we find that IRF5 knockdown profoundly decreases Nod2-mediated MAPK and NF-κB pathway activation, whereas the PI3K and mammalian target of rapamycin pathways are not impaired. Finally, the IRF5 rs2004640 polymorphism is a major determinant of the variance (r(2) = 0.53) in Nod2-induced cytokine secretion by monocyte-derived cells from different individuals. We therefore show a profound contribution of a single gene to the variance in interindividual PRR-induced cytokines. The hyperresponsiveness of IRF5 disease-associated polymorphisms to a wide spectrum of microbial triggers has broad implications on global immunological responses, host defenses against pathogens, and inflammatory/autoimmune disease susceptibility.
authors.affiliation: Department of Internal Medicine, Yale University, New Haven, CT 06510, USA.
authors.forename: Matija
authors.initials: M
authors.lastname: Hedl
authors.forename: Clara
authors.initials: C
authors.lastname: Abraham
mesh_terms: D001327:Autoimmune Diseases / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D002478:Cells, Cultured; D015331:Cohort Studies; D016207:Cytokines / Q000378:metabolism*; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation / Q000276:immunology*; D005838:Genotype; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D050835:Interferon Regulatory Factors / Q000235:genetics*; D009000:Monocytes / Q000276:immunology* / Q000378:metabolism* / Q000382:microbiology; D053473:Nod2 Signaling Adaptor Protein / Q000502:physiology; D011110:Polymorphism, Genetic / Q000276:immunology*; D061251:Primary Cell Culture; D051192:Receptors, Pattern Recognition / Q000235:genetics* / Q000502:physiology; D012307:Risk Factors
chemical_list: D016207:Cytokines; C431713:IRF5 protein, human; D050835:Interferon Regulatory Factors; C429018:NOD2 protein, human; D053473:Nod2 Signaling Adaptor Protein; D051192:Receptors, Pattern Recognition